1. Liver triacylglycerol accumulation but not postprandial lipemia is reduced by a skim milk powder diet in male rats.
- Author
-
Medak KD, McKie GL, Peppler WT, Shamshoum H, Dibe HA, Mutch DM, Josse AR, and Wright DC
- Subjects
- Rats, Male, Animals, Triglycerides, Milk, Lipids, Powders, Diet, Liver metabolism, Fatty Acids, Monounsaturated, Fatty Acids metabolism, Dietary Fats metabolism, Hyperlipidemias etiology, Cardiovascular Diseases metabolism
- Abstract
Increases in postprandial lipids are linked to the development of cardiometabolic and fatty liver disease. Prior work has suggested that dairy possesses beneficial cardiometabolic effects and thus the aim of the current investigation was to test the hypotheses that the habitual consumption of dairy, in the form of skim milk powder (SMP), would protect against increases in circulating lipids and liver lipid accumulation following an oral fat challenge in rats. Male rats were fed either a semipurified low-fat control diet with casein or a diet with an equivalent amount of protein (∼13% kcal) provided through skim milk powder (SMP) for 6 weeks (n = 40/group). Rats were then given an oral gavage of palm oil (5 mL/kg body weight) or an equivalent volume of water, and serum and liver were harvested 90 minutes or 4 hours after. Rats fed the SMP diet gained less weight than controls but there were no differences in glucose tolerance between groups. The fat gavage increased serum lipids in both diet groups, whereas there was a main effect of the fat challenge to increase, and the SMP diet, to decrease liver triacylglycerol accumulation. The percentage of saturated and monounsaturated fatty acids and the protein content/activity of lipogenic enzymes were reduced in livers from SMP-fed rats, whereas the percentage of polyunsaturated fatty acids was increased. In summary, we provide evidence that SMP consumption, although not protecting against postprandial lipemia, markedly attenuates triacylglycerol accumulation and the relative amount of saturated and monounsaturated fatty acids in the liver., Competing Interests: Author declarations After completion of data collection, W.T.P. became and is a current employee of AstraZeneca. There are no conflicts of interest to declare., (Copyright © 2023 Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF